Tata 1mg’s net loss plummeted to Rs 313 crore from Rs 1,255 crore in the previous financial year. Over 80% of the company’s operating reven...

PharmEasy’s parent firm API Holdings cut down its advertising and promotional expenses to Rs 235 crore, less than half of what it incurred ...

Tata 1mg had a 31% market share in September 2023 against 19% in October 2022 while PharmEasy slipped to 15% from about 33% during the same...

Mumbai-based epharmacy platform PharmEasy is likely to be valued at $500-600 million compared to the $5.6 billion valuation in 2021

As of March 31, 2023, funds managed by Janus Henderson valued their stake in the startup at $2.7 billion – less than half of the $5.6 billi...

PharmEasy was supposed to raise equity of around Rs 1,000 crore, or about $120 million, linked to its burn rate velocity. It has failed to ...

The epharmacy held discussions with CDPQ, ADQ; convertible notes are also being discussed amid valuation corrections and markdowns.

The global investor, which picked a stake in PharmEasy in September 2021, has reduced the valuation of its holding in the firm by half, whi...

PharmEasy’s parent API Holdings has also delayed internal plans for a potential initial public offering (IPO) to 2025, the people privy to ...

The Mumbai-based firm is also stitching up a private financing round through a rights issue where company founders are expected to invest p...

Through strategic acquisitions in the healthcare space, the company seems to be aiming to create “a holistic healthcare ecosystem”. From th...

Thyrocare Technologies Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 5758.02 Crore) operating in Hos...

API Holdings — the parent company of PharmEasy — has appointed five independent directors to its board. India's biggest online pharmacy is ...

Thyrocare is primarily a B2B diagnostic services provider. With PharmEasy’s presence, it will no longer be seen as a conventional diagnosti...

E-pharmacy conducts $3 million Esop buyback; Tiger Global also putting primary capital in Mumbai-based startup.

The total size of the transaction could be about $40 million and may value the company at about $1.8 billion, up from the current $1.5 bill...

In August, Medlife appointed former Myntra CEO Ananth Narayanan as CEO and cofounder, with a mandate to head day-to-day operations, raise f...